Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2023 Jul;71(7):2041-2045.
doi: 10.1111/jgs.18405. Epub 2023 May 25.

Is it time to repurpose geroprotective diabetes medications for prevention of dementia?

Diana He  1 , Sandra Aleksic  2
Affiliations
Editorial

Is it time to repurpose geroprotective diabetes medications for prevention of dementia?

Diana He et al. J Am Geriatr Soc. 2023 Jul.
No abstract available

PubMed Disclaimer

Conflict of interest statement

Conflict of interest: Dr. Aleksic reports stock ownership by her spouse (value of $3,000) in Novo Nordisk, the company which produces GLP1-RAs and insulins, the classes of medications which were mentioned in the article. Dr. He declares that there is no conflict of interest.

Figures

Figure 1.
Figure 1.
Postulated mechanisms by which newer diabetes medications with geroprotective properties may reduce incidence of dementia. SGLT-2 – sodium-glucose co-transporter 2, GLP-1RAs – glucagon-like peptide 1 receptor agonists, mTORC1 – mammalian target of rapamycin complex 1 (Created with BioRender.com).
See this image and copyright information in PMC

Comment on

References

    1. Wang Y, Li C, Liang J, et al. Onset age of diabetes and incident dementia: A prospective cohort study. J Affect Disord. Mar 02 2023;329:493–499. doi: 10.1016/j.jad.2023.02.138 - DOI - PubMed
    1. Centers for Disease Control and Prevention. National Diabetes Statistics Report. https://www.cdc.gov/diabetes/data/statistics-repoir/index.html. Accessed 03/11/2023.
    1. Sun H, Saeedi P, Karuranga S, et al. IDF Diabetes Atlas: Global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045. Diabetes Res Clin Pract. Jan 2022;183:109119. doi: 10.1016/j.diabres.2021.109119 - DOI - PMC - PubMed
    1. Luchsinger JA, Tang MX, Shea S, Mayeux R. Hyperinsulinemia and risk of Alzheimer disease. Neurology. Oct 12 2004;63(7):1187–92. doi: 10.1212/01.wnl.0000140292.04932.87 - DOI - PubMed
    1. Talbot K, Wang HY, Kazi H, et al. Demonstrated brain insulin resistance in Alzheimer's disease patients is associated with IGF-1 resistance, IRS-1 dysregulation, and cognitive decline. J Clin Invest. Apr 2012;122(4):1316–38. doi: 10.1172/JCI59903 - DOI - PMC - PubMed

MeSH terms

Substances